Combined treatment for PTSD and chronic pain
Official title: Pilot of an Integrated Treatment for Comorbid PTSD and Chronic Pain
Run by Weill Medical College of Cornell University · NCT07225049 · Data updated 2026-11-12
This project will try a combined therapy that treats PTSD and long-term pain at the same time for adults who have both conditions.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | Weill Medical College of Cornell University Academic / other |
| Locations | 1 site (New York, New York) |
| Status | Recruiting |
| Started | December 8, 2025 |
| Main results expected | August 2027 |
| Study ends | August 2027 |
| Registry record updated | June 15, 2026 |
| Trial ID | NCT07225049 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 or older who speak English, meet CAPS-5 criteria for PTSD, report chronic pain severity of 4/10 or higher over the past three months, are medically stable, and have had stable psychotropic medications for at least 60 days are the intended participants.
✕Probably not a fit
People with a lifetime diagnosis of schizophrenia, other psychotic disorder, or bipolar I disorder, those with moderate to severe recent substance use, those currently receiving evidence-based PTSD or pain psychotherapy, or those with significant cognitive impairment are unlikely to benefit from or be eligible for this pilot.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a single-arm pilot testing an integrated intervention that delivers evidence-based PTSD therapy (Prolonged Exposure) together with cognitive-behavioral therapy for chronic pain, rather than offering them one after the other. Adults who meet diagnostic criteria for PTSD and report clinically meaningful chronic pain will receive the combined protocol while remaining on stable medications. Outcomes will include changes in PTSD symptoms, pain severity, functional impairment, and treatment retention to gauge feasibility and preliminary efficacy. The work is conducted at Weill Cornell Medicine with in-person outpatient therapy visits.
Why it matters
Potential benefit: If successful, delivering PTSD and pain treatment together could reduce both symptoms more efficiently and lower dropout compared with treating each condition separately.
How similar studies have gone: Gold-standard treatments like Prolonged Exposure and CBT for chronic pain are effective individually, but simultaneous integrated approaches are relatively novel and have limited prior testing.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years or older * English-speaking * Currently meets criteria for PTSD, assessed by the CAPS-5 (any trauma type) - Chronic pain, assessed by greater than or equal to 4 on a scale of 0-10 pain severity over the past 3 months * Medically stable at the time of study enrollment (chronic illness and disability does not prevent attendance of outpatient therapy sessions) * Stable on psychotropic medication for past 60 days * Agreed to not change current medication or pain-related treatments over the course of the study unless medically necessary * Must be located in the state of New York for virtual assessments and treatment sessions Exclusion Criteria: * Lifetime diagnosis of schizophrenia, other psychotic disorder, or bipolar I disorder * Participation in concurrent evidence-based psychological treatment for PTSD or chronic pain during the past 3 months * Participants must not participate in an evidence-based psychological treatment for either PTSD or pain during the course of the study. * Moderate or severe substance use in the past 90 days * Cognitive impairment to the degree that the patient cannot provide informed consent or fill out assessment measures * Participants who in the PI's judgement pose a current homicidal or suicidal risk
Where it's running
-
Weill Cornell Medicine
New York, New York, United States Recruiting
Study contacts
- Principal investigator: JoAnn Difede, PhD — Weill Medical College of Cornell University
- Study coordinator: Mariel Emrich, MS
- Email: mae2050@med.cornell.edu
- Phone: 212-821-0783
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Internet-delivered ACT for youth with PTSD and chronic pain
A small pilot study will test a web-based Acceptance and Commitment Therapy program for teens and young adults with PTSD and chronic pain to see if it helps with symptoms and functioning.
-
Preventing chronic pain by treating PTSD during acute pain episodes
This study is testing if treating PTSD symptoms during episodes of acute pain can help prevent people from developing chronic pain later on.
-
Internet-delivered therapy for PTSD and chronic pain
This study is testing whether online therapy can help people with PTSD and chronic pain feel better compared to those who wait to start the treatment.
-
Observational study on integrative medical care for chronic illnesses and mental health
This study is testing how a team approach to integrative medical care can help adults and children with chronic illnesses and mental health issues feel better.
-
Cognitive Rehabilitation of Everyday Goals With GMT: How Different Ways of Delivery Work
This study tests Goal Management Training to see if a Swedish version helps adults with acquired brain injury or chronic pain improve practical goal-directed thinking and daily functioning.
-
One-time Pain Reprocessing Therapy session for chronic pain at The Ottawa Hospital
A single four-hour session of Pain Reprocessing Therapy is being tested to see if it can help adults with chronic pain feel better and have less pain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.